SPHERA FUNDS MANAGEMENT LTD. 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-06 11:27 am Sale |
2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
SPHERA FUNDS MANAGEMENT LTD. | 1,042 1.990% |
-1,076 (-50.82%) |
Filing |
| 2022-02-14 06:15 am Purchase |
2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
SPHERA FUNDS MANAGEMENT LTD. | 2,118 5.100% |
6 (+0.30%) |
Filing |
| 2021-03-18 12:59 pm Purchase |
2021-03-12 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
SPHERA FUNDS MANAGEMENT LTD. | 2,112 6.290% |
2,112 (New Position) |
Filing |